期刊文献+

终末期肾病患者肿瘤坏死因子α基因多态性与微炎症状态的相关性研究

Relationship between tumor necrosis factor alpha gene polymorphism and microinflammatory state in end-stage renal diseases
下载PDF
导出
摘要 目的探讨肿瘤坏死因子(TNF-α)基因G-308A位点的遗传多态性和终末期肾病(ESRD)患者微炎症状态的相关关系。方法采用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)检测30例健康对照者、60例终末期肾病患者该位点的基因多态性;应用ELISA测定血清C反应蛋白(CRP)、TNF-α浓度。结果 TNF-α-308AG+AA基因型在ESRD组、健康对照组分布频率分别为12%、7%,两组在基因型分布频率、等位基因频率差异均无统计学意义。ESRD组的不同基因型血清CRP、TNF-α浓度未发现差异;ESRD患者血清CRP、TNF-α浓度与基因型之间的Spearman相关系数分别为0.101和0.09(P>0.05)。结论 TNF-α基因G-308A位点的基因多态性与ESRD的发生无相关性。ESRD患者血清CRP、TNF-α浓度升高与TNF-α基因G-308A位点的基因多态性无关。 Objective To explore the relationship of between tumor necrosis alpha (TNF-α) gene G308A polymorphism and microinflammatory state in end-stage renal diseases (ESRD).Methods The G-308A polymorphism of TNF-α promoter was genotyped by using PCR-RFLP method in 60 patients with ESRD and 30 cases of control of Han ethnic group in Guangdong ; the serum levels of C-reactive protein (CRP), TNF-α were determined using ELISA assay.Results The frequency of AG+AA genotypes of TNF-α-308 appears to be 12% in the ESRD group, and 7% in the control.No significant difference was found in genotype distribution and allelic frequency between the ESRD group and the control.The serum levels of CRP and TNF-α in the ESRD group showed no difference between GG genotype and AG+AA genotype.It showed that there was no significant correlation between the genotypes and the serum levels of CRP (r=0.101) or TNF-α (r=0.09) using the Spearman's rank correlation.Conclusion TNF-α gene G308A polymorphism is not associated with ESRD and don't contribute to the increased serum levels of CRP and TNF-α in the ESRD patients.
出处 《解剖学研究》 CAS 2010年第3期189-192,共4页 Anatomy Research
关键词 肿瘤坏死因子 终末期肾病 基因多态性 微炎症 Tumor necrosis factor End-stage renal diseases Gene polymorphism Microinflammation
  • 相关文献

参考文献3

二级参考文献23

  • 1Maciej Banach,Jarostaw Drozdz,Piotr Okonski,Jacek Rysz.Immunological Aspects of the Statins' Function in Patients with Heart Failure:A Report from the Annual Conference of ESC-Heart Failure 2005[J].Cellular & Molecular Immunology,2005,2(6):433-437. 被引量:7
  • 2梁馨苓,史伟,章斌,刘双信,林秋雄,黄美萍,王文健,叶智明,何朝生.终末期肾病患者心血管事件与血清胎球蛋白A及冠脉钙化的关系[J].中华肾脏病杂志,2006,22(6):336-340. 被引量:25
  • 3Cano NJ, Roth H, Aparicio M, et al. Malnutrition in hemodialysis diabetic patients:evaluation and prognostic influence [J].Kidney Int, 2002,62(2):593 601.
  • 4Park CW, Shin YS, Kim CM, et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients[J]. Am J Kidney Dis, 2002, 40(6): 1230-1239.
  • 5Chauveau P, Level C, Lasseur C, et al.C reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2 year prospective study[J]. J Ren Nutr, 2003, 13(2):137-143.
  • 6Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure[J]. Kidney Int, 1999,55(5):1899-1911.
  • 7Locatelli F, Manzoni C, Di Filippo S, et al. The importance of convective transport[J] . Kidney Int Suppl,2002, (80): 115-120.
  • 8Iseki K, Tozawa M, Yoshi S, et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients[J]. Nephrol Dial Transplant, 1999,14(8):1956 1960.
  • 9Korevaar J C, vanM anen J G, Dekker F W, et al. Effect of an increase in C reactive protein level during a hemodialysis session on mortality[J]. J Am Soc Nephrol, 2004,15(11): 2916 2922.
  • 10Zimmermann J, Herrlinger S, P ruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[J].Kidney Int, 1999,55(2):648-658.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部